Implanted sensors may foresee heart failure crises

NCT ID NCT07753135

Ongoing Knowledge-focused Sponsor: Samsung Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study looks at whether sensors inside implanted heart devices can warn of worsening heart failure. Researchers will track 500 adults with heart failure or cardiomyopathy who have a Boston Scientific ICD or CRT-D equipped with HeartLogic, Sleep Incline, and Apnea Scan functions. By collecting data from routine device checks and remote monitoring, they aim to see if changes in sensor readings are linked to heart failure events like hospitalizations or emergency visits. The goal is to improve remote monitoring and help doctors intervene earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy defibrillator (CRT-D) with HeartLogic, Sleep Incline, and Apnea Scan functions
What this could lead to: If sensor changes reliably predict heart failure worsening, this could enable earlier interventions, fewer hospitalizations, and better remote care for patients with heart failure.
What could go wrong: This is an observational study, so it cannot prove cause and effect. The findings may not apply to all patients, and sensor data might not consistently predict worsening heart failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOMYOPATHY HEART FAILURE

Contacts and locations

Locations

Samsung Medical Center

Seoul, Seoul, 06351, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.